Immix Biopharma, Inc. IMMX Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s operating lease liability payments due?
- Immix Biopharma, Inc. (IMMX) reported operating lease liability payments due of $1.39M in Q1 2026.
- How has Immix Biopharma, Inc.'s operating lease liability payments due changed year-over-year?
- Immix Biopharma, Inc.'s operating lease liability payments due decreased by 6.8% year-over-year, from $1.5M to $1.39M.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.